SAGE's new Therapeutic Advances series of journals is a bi-monthly forum for researchers and clinicians, each focusing on clinical developments in a specific therapeutic area. They provide a vehicle for rapid, rigorously peer-reviewed publication of original research and review articles. Each title has a prestigious Editor-in-Chief, Associate Editors and an Editorial Board of internationally-respected key opinion leaders. Indexing is currently on EMBASE, applications for ISI and medicine listings are ongoing and we are now regularly reviewed by the Faculty of 1000 Medicine and MEDSCAPE.
In these pages you will find information for those working in Medical Communications or Medical Affairs. Authors can find out how to submit a paper. In addition we detail our Therapeutic Advances Peer Review Statement and forthcoming titles to the Therapeutic Advances Series
The Therapeutic Advances Series |

- Therapeutic Advances in Cardiovascular Disease
Encompassing all of the disciplines in cardiovascular disease by providing cutting-edge articles and reviews on pharmacology and medicine -

For FREE online access

- Therapeutic Advances in Gastroenterology
Specialises in latest clinical research and reviews in gastroenterology and hepatology -

For FREE online access

- Therapeutic Advances in Neurological Disorders
Publication of drug treatment innovations and advances in this diverse area of medicine. -

For FREE online access

- Therapeutic Advances in Respiratory Disease
A forum for the dissemination of knowledge about the pharmacological treatment of respiratory disease. -

For FREE online access
Peer review statement |
![]() |
We strongly endorse the value and importance of peer review in scholarly journals publishing. All original text research and review articles submitted to Therapeutic Advances journals will be subject to comment and external review by no less than two reviewers, adhering to a single-blind peer-review process in which the reviewer's name is routinely witheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed as rapidly as possible, and a first editorial decision is generally reached within 2-3 weeks of submission. Authors are invited to suggest reviewers, but the Editors are under no obligation to use all or any of these individuals. Manuscripts are reviewed initially by the Editors and only those papers that meet the scientific and editorial standards of the journals, and fit within the aims and scope, will be sent for outside review.
Forthcoming titles |
![]() |
We are working to expand the range of therapeutic areas covered by the series. Forthcoming titles covering the following areas include Cancer, Dermatology, Disease Management and Outcomes, Drug Safety & Interactions, Endocrine and Metabolism, Ethnopharmacology gerontology, Immunomodulators, Infectious Diseases, Medical Devices and Diagnostics, Musculoskeletal disorders, Ophthalmology, Pediatrics, Personalized Medicine, Pharmacogenomics, Regenerative Medicine, Reproductive Medicine, incl. Men's and Women's health, Urology.
![]() |
![]() |
![]() |
![]() |
| Therapeutic Advances in Cardiovascular Disease |
Therapeutic Advances in Gastroenterology |
Therapeutic Advances in Neurological Disorders |
Therapeutic Advances in Respiratory Disease |
for FREE online access |
for FREE online access |
for FREE online access |
for FREE online access |
Therapeutic Advances - Your Publishing Partner |
The Therapeutic Advances journals have established a strong reputation within their respective fields, making them an ideal choice for showcasing important research. The journals have superb production values and are printed on high-quality glossy paper – we apply the same high standards to our reprints and supplements. These can be customised according to your needs, rapidly produced and delivered. Translations are available. Why not get maximum exposure through one of the following:
Reprints
Reprints of articles pertaining to your company’s mission serve as excellent marketing support for conference hand-outs, collateral sales and direct mail pieces. We can also supply electronic reprints in PDF format, for posting on a website or disseminating by email.
Advertising
To place your advertisements on the back cover, inside front cover, inside back cover or other specified positions, please contact the Commercial Sales Executive (details below).
Supplements
Peer-reviewed journal supplements to regular issues provide the ideal opportunity to communicate with the journal’s readership. The journal Editors also welcome appropriate proposals for sponsored or themed supplements.
Our dedicated commercial sales team can provide more information. Please contact Matt Schlag - matt.schlag@sagepub.co.uk (Cardiovascular Disease and Gastroenterology) or Tamara Haq - tamara.haq@sagepub.co.uk (Respiratory Disease and Neurological Disorders) for more information.
![]() |
Therapeutic Advances
|
![]() |
Therapeutic Advances
|
![]() |
Therapeutic Advances
|
![]() |
Therapeutic Advances
|
Why Publish in Therapeutic Advances?
|
![]() |
Therapeutic Advances
|
![]() |
Therapeutic Advances
|
![]() |
Therapeutic Advances
|
![]() |
Therapeutic Advances
|
Submit Your Paper Today!The Editors are seeking articles from clinicians and researchers working in the fields of Respiratory Disease, Cardiovascular Disease, Gastroenterology and Neurology. Instructions on submitting articles to the Therapeutic Advances journals can be found on each journal’s homepage. Submission is quick and easy via our online system, SAGETRACK, powered by Scholar One’s Manuscript Central. |





